Anavex Life Sciences Corp. (AVXL)

1.19 -0.11 (-8.46%) USD  |  NASDAQ  |  Oct 30, 16:00
1.19 0.00 (0.00%) Pre-Market: 20:00
More

Anavex Life Sciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
May 27, 2026 --
April 02, 2026 --
March 31, 2026 --
March 26, 2026 --
March 23, 2026 --
March 19, 2026 --
February 10, 2026 --
February 09, 2026 --
January 20, 2026 --
January 06, 2026 --
December 19, 2025 --
December 17, 2025 --
December 15, 2025 --
November 28, 2025 --
November 26, 2025 --
Date Value
November 19, 2025 --
November 14, 2025 --
October 29, 2025 --
October 07, 2025 --
September 10, 2025 --
August 22, 2025 --
May 16, 2025 --
May 14, 2025 --
May 02, 2025 --
April 07, 2025 --
March 31, 2025 --
February 27, 2025 --
February 18, 2025 --
May 09, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Vaxcyte, Inc. Upgrade
Foghorn Therapeutics, Inc. Upgrade
Connect Biopharma Holdings Ltd. Upgrade
Caribou Biosciences, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade